HSU JASON purchased 1.1% of their position (9.20K shares) of IMMIX BIOPHARMA, INC. on the open market
Open‑market purchase worth $19.5K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 7/31/2024ACC: 0001493152-24-029810
+9.20K
Net shares
Net buyer
$19.5K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
9.20K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.20K
Price / share
$2.07
Trade value
$6.64K
% of position
0.4%
7/18/2024
813K→816.20K
Common Stock
Direct
Shares
+6K
Price / share
$2.15
Trade value
$12.88K
% of position
0.7%
7/24/2024
816.20K→822.20K
Total
Net shares
+9.20K
Net value
$19.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/18/2024 | P · Purchase | +3.20K | $2.07 | $6.64K | 0.4% | 813K | 816.20K |
| Common Stock Direct | 7/24/2024 | P · Purchase | +6K | $2.15 | $12.88K | 0.7% | 816.20K | 822.20K |
| Total | +9.20K | $19.52K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned3.92M
Common Stock
IndirectShares owned50K
Total
3.97M indirect3.97M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.92M | Indirect |
| Common Stock | 50K | Indirect |
| Total | 3.97M | 3.97M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported